US HB724 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on February 2 2021 - 25% progression, died in committee
Action: 2021-02-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 2 2021 - 25% progression, died in committee
Action: 2021-02-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
Title
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021
Sponsors
| Rep. Chip Roy [R-TX] | Rep. Mark Green [R-TN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-02-03 | House | Referred to the Subcommittee on Health. |
| 2021-02-02 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-02-02 | House | Introduced in House |
Same As/Similar To
SB154 (Same As) 2021-02-02 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/724/all-info |
| Text | https://www.congress.gov/117/bills/hr724/BILLS-117hr724ih.pdf |
